How many tumor suppressor genes are involved in human lung carcinogenesis?

被引:94
作者
Kohno, T [1 ]
Yokota, J [1 ]
机构
[1] Natl Canc Ctr, Res Inst, Div Biol, Chuo Ku, Tokyo 1040045, Japan
关键词
D O I
10.1093/carcin/20.8.1403
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
To date, only a limited number of tumor suppressor genes have been identified as being inactivated in lung cancer. The p53 and RE genes are frequently inactivated by genetic alterations such as chromosomal deletions and loss-of-function mutations, while the pld gene is inactivated not only by genetic alterations but also by transcriptional silencing due to hypermethylation, Recently, it was shown that the FHIT gene encompassing the chromosomal fragile site, FRA3B, is also inactivated in a large proportion of lung cancers. Several lines of evidence indicate the presence of additional tumor suppressor genes involved in lung carcinogenesis. Lung cancer cells often show deletions at multiple chromosomal regions, and deletion mapping studies have defined more than 30 regions dispersed on 21 different chromosome arms as candidate tumor suppressor loci. Several chromosomal regions hypermethylated in lung cancer cells and a number of chromosomal fragile sites have been mapped to the regions deleted in lung cancer. These chromosomal loci can harbor unknown tumor suppressor genes inactivated in lung cancer. Studies on the inherited susceptibility to lung cancer in mice have also indicated the presence of additional tumor suppressor genes for lung cancer, Further analyses of these loci should elucidate how many tumor suppressor genes are involved in human lung carcinogenesis. Molecular and functional analyses of those genes will make it possible to fully understand the molecular mechanism of lung carcinogenesis.
引用
收藏
页码:1403 / 1410
页数:8
相关论文
共 132 条
  • [1] The somatic mutation frequency of the transforming growth factor beta receptor type II gene varies widely among different cancers with microsatellite instability
    Abe, T
    Hong, OY
    Migita, T
    Kato, Y
    Kimura, M
    Shiiba, K
    Sunamura, M
    Matsuno, S
    Horii, A
    [J]. EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 1996, 22 (05): : 474 - 477
  • [2] Loss of heterozygosity (LOH) at 17q and 14q in human lung cancers
    Abujiang, P
    Mori, TJ
    Takahashi, T
    Tanaka, F
    Kasyu, I
    Hitomi, S
    Hiai, H
    [J]. ONCOGENE, 1998, 17 (23) : 3029 - 3033
  • [3] MICROSATELLITE INSTABILITY IN PRIMARY AND METASTATIC LUNG CARCINOMAS
    ADACHI, J
    SHISEKI, M
    OKAZAKI, T
    ISHIMARU, G
    NOGUCHI, M
    HIROHASHI, S
    YOKOTA, J
    [J]. GENES CHROMOSOMES & CANCER, 1995, 14 (04) : 301 - 306
  • [4] [Anonymous], LUNG CANC PRINCIPLES
  • [5] Arzimanoglou II, 1998, CANCER-AM CANCER SOC, V82, P1808, DOI 10.1002/(SICI)1097-0142(19980515)82:10<1808::AID-CNCR2>3.0.CO
  • [6] 2-J
  • [7] Atm haploinsufficiency results in increased sensitivity to sublethal doses of ionizing radiation in mice
    Barlow, C
    Eckhaus, MA
    Schäffer, AA
    Wynshaw-Boris, A
    [J]. NATURE GENETICS, 1999, 21 (04) : 359 - 360
  • [8] Baylin SB, 1998, ADV CANCER RES, V72, P141
  • [9] BENNETT WP, 1993, CANCER RES, V53, P4817
  • [10] 3 TUMOR-SUPPRESSOR REGIONS ON CHROMOSOME-11P IDENTIFIED BY HIGH-RESOLUTION DELETION MAPPING IN HUMAN NON-SMALL-CELL LUNG-CANCER
    BEPLER, G
    GARCIABLANCO, MA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (12) : 5513 - 5517